Stocks and Investing Stocks and Investing
Thu, March 17, 2022
Wed, March 16, 2022

Tejas Savant Maintained (SOPH) at Buy with Decreased Target to $17 on, Mar 16th, 2022


Published on 2024-10-27 20:06:32 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "SOPHiA GENETICS SA" (SOPH) at Buy with Decreased Target from $18 to $17 on, Mar 16th, 2022.

Tejas, nor any peers, have made any analyst calls on SOPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources